About this trial
The goal of this randomized interventional clinical trial is to learn if a standardized lung volume optimization maneuver (LVOM) is beneficial in
1. study) children undergoing biventricular repair of their congenital heart disease (CHD) with cardiopulmonary bypass and 2. study) in children with severe respiratory failure at risk for or need for ECMO.
The main questions it aims to answer are:
Main hypotheses of CHD study: Does a standardized PEEP-Titration maneuver, to optimize end-expiratory lung volume improve:
* cardiac performance * lung function
Does it make a difference in:
* length of ventilation * ventilation/perfusion mismatch of the lung * need for vasopressor support?
Main hypotheses of ECMO study:
Does a LVOM in children/infants with severe respiratory failure /ARDS
* improve lung compliance and gas exchange * facilitate lung protective ventilation according to PALICC-2 guidelines * improve lung aeration and V/Q-matching assessed with EIT
Does it make a difference in
* need for ECMO * duration of ECMO runs * hemodynamics stability
Eligibility criteria
Qualifiers
congenital heart disease
surgery with cardiopulmonary bypass
Disqualifiers
single ventricle physiology
ECMO/VAD
<36weeks of gestational age
chronic lung disease
Trial design
Treatments tested in this trial
- End-expiratory lung volume optimization maneuver with PEEP titration
- Standard Care (in control arm)